Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02917876 · ClinicalTrials.gov registry record
Predictors of De-novo Development of Obstructive Sleep Apnea in Pregnancy
A clinical trial of Obesity and Pregnancy, sponsored by The Miriam Hospital.
- Active
- Registry status
- 450
- Enrollment target
- 1
- Study location
NCT02917876 is a study of Obesity and Pregnancy that is active but no longer recruiting, run by The Miriam Hospital. The registered enrollment target is 450 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (45% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02917876, a study of Obesity and Pregnancy, is active but no longer recruiting, sponsored by The Miriam Hospital.
- ACTIVE NOT RECRUITING
- Registry status
- 450 participants
- Enrollment target
- 1
- Study location
Study Summary
This study seeks to understand the physical, physiologic and biologic features that predispose a woman to the development of obstructive sleep apnea once they are exposed to the cardiopulmonary and metabolic physiological changes of pregnancy. Knowing these specific predictive factors can help identify a population at risk and guide clinicians to develop suitable targeting screening strategies.
Conditions Studied
Study Locations (1)
Rhode Island
- The Miriam Hospital - Providence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 450 participants |
| Start Date | 2016-11 |
| Est. Completion | 2025-05-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02917876
The ClinicalTrials.gov registry entry for NCT02917876 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 450 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (45% lower). The listed sponsor is The Miriam Hospital, which has 136 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Obesity appearing as the primary indexed condition, and to 0 interventions.
NCT02917876 reports 1 study location spanning 1 distinct geographic area - top geographies include Rhode Island.
Frequently Asked Questions
What is clinical trial NCT02917876 about?
NCT02917876 is a clinical study titled "Predictors of De-novo Development of Obstructive Sleep Apnea in Pregnancy". This study seeks to understand the physical, physiologic and biologic features that predispose a woman to the development of obstructive sleep apnea once they are exposed to the cardiopulmonary and metabolic physiological changes of pregnancy. Knowing these specific predictive factors can help ident...
What is the current status of trial NCT02917876?
This trial is currently active not recruiting. The enrollment target is 450 participants. The study started on 2016-11. Estimated completion is 2025-05-01.
What conditions does trial NCT02917876 study?
This clinical trial studies the following conditions: Obesity, Pregnancy, Obstructive Sleep Apnea, Sleep.
Who is sponsoring clinical trial NCT02917876?
This trial is sponsored by The Miriam Hospital, which has 136 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02917876 being conducted?
This trial has 1 study location across Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Hip Flexion Feedback System for Exercise Monitoring in Individuals With Osteoarthritis and Obesity
RECRUITING · Phase 1
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation
RECRUITING · Phase 2
-
Tirzepatide: Reversal of Lipotoxicity and Adipose Tissue Dysfunction in Humans With Overweight/Obesity
RECRUITING · Phase 2
-
Tai Chi as a Novel Strategy to Increase Physical Activity Among Adults Pursuing Metabolic and Bariatric Surgery
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.